BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 24461094)

  • 21. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
    Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
    Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Characteristics of CD4
    He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM --A RAPIDLY EVOLVING ENTITY. CASE REPORT.
    Andrese E; Solovăstru LG; Dimofte G; Ferariu D; Porumb V; Vâţă D; Iancul LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):379-83. PubMed ID: 26204640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
    Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
    Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
    Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
    Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea.
    Kim HS; Kim HJ; Kim SH; Choi JY; Ko YH; Kim WS; Jung CW; Kim SJ
    Korean J Intern Med; 2017 Sep; 32(5):890-899. PubMed ID: 28870016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience.
    Demiröz AS; Demirkesen C; Salihoğlu A; Tüzüner N
    Turk J Haematol; 2020 Feb; 37(1):48-52. PubMed ID: 31752482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blastic plasmacytoid dendritic cell neoplasm.
    Lim D; Goodman H; Rademaker M; Lamont D; Yung A
    Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
    Nong L; Wang W; Liang L; Li D; Li X; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.
    Bétrian S; Guenounou S; Luquet I; Demur C; Huynh A; Ysebaert L; Recher C; Huguet F
    Hematol Oncol; 2017 Jun; 35(2):252-255. PubMed ID: 28620927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings.
    Zheng G; Schmieg J; Guan H; Ali SZ
    Acta Cytol; 2012; 56(2):204-8. PubMed ID: 22378086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
    Ding Y; Yang J; Lindsey K
    Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion : a borderline case between acute monocytic leukemia.
    Takiuchi Y; Maruoka H; Aoki K; Kato A; Ono Y; Nagano S; Arima H; Inoue D; Mori M; Tabata S; Yanagita S; Matsushita A; Nishio M; Imai Y; Imai Y; Ito K; Fujita H; Kadowaki N; Ishikawa T; Takahashi T
    J Clin Exp Hematop; 2012; 52(2):107-11. PubMed ID: 23037626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.
    Sugimoto KJ; Shimada A; Yamaguchi N; Imai H; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2013; 6(11):2603-8. PubMed ID: 24228127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.